| Diabetic neuropathies: a statement by the American Diabetes Association AJM Boulton, AI Vinik, JC Arezzo, V Bril, EL Feldman, R Freeman, ... Diabetes care 28 (4), 956-962, 2005 | 3355 | 2005 |
| Diabetic neuropathy: a position statement by the American Diabetes Association R Pop-Busui, AJM Boulton, EL Feldman, V Bril, R Freeman, RA Malik, ... Diabetes care 40 (1), 136, 2016 | 2831 | 2016 |
| Diabetic neuropathy EL Feldman, BC Callaghan, R Pop-Busui, DW Zochodne, DE Wright, ... Nature reviews Disease primers 5 (1), 41, 2019 | 1786 | 2019 |
| A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy EL Feldman, MJ Stevens, PK Thomas, MB Brown, N Canal, DA Greene Diabetes care 17 (11), 1281-1289, 1994 | 1614 | 1994 |
| Diabetic neuropathy: clinical manifestations and current treatments BC Callaghan, HT Cheng, CL Stables, AL Smith, EL Feldman The lancet NEUROLOGY 11 (6), 521-534, 2012 | 1486 | 2012 |
| Oxidative stress in the pathogenesis of diabetic neuropathy AM Vincent, JW Russell, P Low, EL Feldman Endocrine reviews 25 (4), 612-628, 2004 | 1484 | 2004 |
| Diabetic neuropathy: mechanisms to management JL Edwards, AM Vincent, HT Cheng, EL Feldman Pharmacology & therapeutics 120 (1), 1-34, 2008 | 1162 | 2008 |
| Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic … V Bril, J England, GM Franklin, M Backonja, J Cohen, D Del Toro, ... Pm&r 3 (4), 345-352. e21, 2011 | 957 | 2011 |
| New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain EL Feldman, KA Nave, TS Jensen, DLH Bennett Neuron 93 (6), 1296-1313, 2017 | 939 | 2017 |
| Enhanced glucose control for preventing and treating diabetic neuropathy BC Callaghan, AA Little, EL Feldman, RAC Hughes Cochrane database of systematic reviews, 2012 | 835 | 2012 |
| Lifestyle intervention for pre-diabetic neuropathy AG Smith, J Russell, EL Feldman, J Goldstein, A Peltier, S Smith, J Hamwi, ... Diabetes care 29 (6), 1294-1299, 2006 | 782 | 2006 |
| Diabetic neuropathy: cellular mechanisms as therapeutic targets AM Vincent, BC Callaghan, AL Smith, EL Feldman Nature Reviews Neurology 7 (10), 573-583, 2011 | 675 | 2011 |
| Genome-wide analyses identify KIF5A as a novel ALS gene A Nicolas, KP Kenna, AE Renton, N Ticozzi, F Faghri, R Chia, ... Neuron 97 (6), 1267-1288, 2018 | 666 | 2018 |
| High glucose‐induced oxidative stress and mitochondrial dysfunction in neurons JW Russell, D Golovoy, AM Vincent, PIA Mahendru, JA Olzmann, ... The FASEB Journal 16 (13), 1738-1748, 2002 | 629 | 2002 |
| Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity PJ Dyck, JW Albers, H Andersen, JC Arezzo, GJ Biessels, V Bril, ... Diabetes/metabolism research and reviews 27 (7), 620-628, 2011 | 623 | 2011 |
| The insulin-like growth factor system and its pleiotropic functions in brain VC Russo, PD Gluckman, EL Feldman, GA Werther Endocrine reviews 26 (7), 916-943, 2005 | 588 | 2005 |
| How does diabetes accelerate Alzheimer disease pathology? C Sims-Robinson, B Kim, A Rosko, EL Feldman Nature Reviews Neurology 6 (10), 551-559, 2010 | 585 | 2010 |
| Microvascular complications of impaired glucose tolerance JR Singleton, AG Smith, JW Russell, EL Feldman Diabetes 52 (12), 2867-2873, 2003 | 574 | 2003 |
| Amyotrophic lateral sclerosis EL Feldman, SA Goutman, S Petri, L Mazzini, MG Savelieff, PJ Shaw, ... The Lancet 400 (10360), 1363-1380, 2022 | 573 | 2022 |
| Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion CL Martin, J Albers, WH Herman, P Cleary, B Waberski, DA Greene, ... Diabetes care 29 (2), 340-344, 2006 | 572 | 2006 |
Brian CallaghanUniversity of MichiganPatvirtintas el. paštas umich.edu
